All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 116 of 206 pages ‹ First < 114 115 116 117 118 > Last ›
HSL3877
Fursiewicz R.
Future of pharmacy: robots and herbs
The Gateway ( University of Alberta Canada ) 2006 Mar 18
http://www.gateway.ualberta.ca/view.php?aid=5928
HSL3883
Lenzer J.
Antidepressants double suicidality in children, says FDA
BMJ 2006 Mar 18;2006;332:626:(doi:10.1136/bmj.332.):
http://bmj.bmjjournals.com/cgi/content/extract/332/7542/626-c
HSL3872
Tanner L.
Spike in anti-psychotics given to children
Associated Press 2006 Mar 17
http://seattlepi.nwsource.com/national/263344_drugs17.html
HSL3881
Bhattacharya S, Coghlan A.
Catastrophic immune response may have caused drug trial horror
New Scientist 2006 Mar 17
http://www.newscientist.com/article/dn8863-catastrophic-immune-response-may-have-caused-drug-trial-horror.html
HSL3873
Nordqvist C.
How Many Ambien Patients Get Up At Night And Remember Nothing?
Medical News Today 2006 Mar 16
http://www.medicalnewstoday.com/healthnews.php?newsid=39759
HSL3876
Munro M.
Medical researchers caught faking it
CanWest News Service 2006 Mar 16
http://www.canada.com/nationalpost/news/story.html?id=a320fffa-9ff7-48b6-b975-86cdef0b4228&rfp=dta
HSL4877
Make or break time in Vioxx drama.
Nature 2006 Mar 16;440:(7082):277
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3094&uid=16541045&db=PubMed&url=http://dx.doi.org/10.1038/440277a
HSL3867
Severe drug reactions from British drug trial leave 2 in critical condition
CBC News Online 2006 Mar 15
http://www.cbc.ca/story/science/national/2006/03/15/drug-reaction060315.html
HSL3868
Hirschler B.
Happy 150th birthday: a new era looms for old age
Reuters 2006 Mar 15
http://today.reuters.co.uk/news/newsArticle.aspx?type=scienceNews&storyID=2006-03-15T162034Z_01_FOR558718_RTRIDST_0_SCIENCE-SCIENCE-AGE-DC.XML
HSL3871
Lister S.
Drug trial axed after patients poisoned
Times Online 2006 Mar 15
http://www.timesonline.co.uk/article/0,,2-2086563,00.html
HSL3912
Prescription drug purchases by Canadian hospitals and pharmacies reach $16.57 billion in 2005
IMS Health Canada 2006 Mar 15
http://www.imshealthcanada.com/htmen/1_0_26.htm
HSL4898
Werko L.
[The 'innovative' drug industry]
Lakartidningen 2006 Mar 15-21;103:(11):857
HSL5671
Baldwin HJ, Droege M, Daniel KL.
A message from the Vioxx case.
Am J Health Syst Pharm 2006 Mar 15;63:(6):503
http://www.ajhp.org/cgi/content/full/63/6/503
HSL6234
Unger T.
[Innovation or pseudo-innovation: that is the question].
Med Klin (Munich) 2006 Mar 15;101:(3):257-62
HSL7321
Giordano SH, Duan Z, Kuo YF, Hortobagyi GN, Freeman J, Goodwin JS.
Impact of a scientific presentation on community treatment patterns for primary breast cancer.
J Natl Cancer Inst. 2006 Mar 15;98:(6):382-8
http://jncicancerspectrum.oxfordjournals.org/cgi/content/full/jnci;98/6/382
HSL3869
CMAJ board member quits, editorial independence questioned
CBC News Online 2006 Mar 14
http://www.cbc.ca/story/science/national/2006/03/14/cmaj-kassirer060314.html
HSL3870
Baby antibiotics 'link to asthma'
BBC News 2006 Mar 14
http://news.bbc.co.uk/1/hi/health/4801118.stm
HSL3901
Friedman R.
Sleep Disorder? Wake Up and Smell the Savanna
New York Times 2006 Mar 14
http://www.boston.com/yourlife/health/other/articles/2006/03/14/sleep_disorder_wake_up_and_smell_the_savanna/
HSL4850
Meek C.
SSRI ads questioned.
CMAJ 2006 Mar 14;174:(6):754
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3051&uid=16534073&db=PubMed&url=http://www.cmaj.ca/cgi/pmidlookup?view=long&pmid=16534073
HSL3904
Roner L.
4th Annual eyeforpharma Sales Force Effectiveness Congress
Eye For Pharma 2006 Mar 13
http://www.eyeforpharma.com/sales2006/
HSL3860
Berenson A.
A Cancer Drug's Big Price Rise Is Cause for Concern
New York Times 2006 Mar 12
http://www.nytimes.com/2006/03/12/business/12price.html?ex=1142830800&en=923825ad9a0a6ec5&ei=5070&emc=eta1
HSL3861
Kolata G.
Studies Find B Vitamins Don't Prevent Heart Attacks
New York Times 2006 Mar 12
http://www.nytimes.com/2006/03/12/health/12cnd-heart.html?ex=1142830800&en=3372356f1677c61e&ei=5070&emc=eta1
HSL3865
Burns G.
New doctors are allergic to freebies
Chicago Tribune 2006 Mar 12
http://www.chicagotribune.com/business/chi-0603120479mar12,1,4458437.story?track=rss
HSL5058
Pollack A.
Take your pills, all your pills: drug makers nag patients to stay the course.
NY Times (Print) 2006 Mar 11;C1:
HSL3853
Bourrier-lacroix B.
Forget 'Julie's Story' – listen to Barbara's story instead!
Canadian Women's Health Network 2006 Mar 10
http://www.cwhn.ca/resources/eating_disorders/barbara.html
HSL3855
Newer antidepressants linked to serious lung disorder in newborns
Health Canada 2006 Mar 10
http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/2006/2006_11_e.html
HSL3859
Tesoriero H.
Vioxx Doctors Wooed by Merck Are Now Its Foes
The wall street journal 2006 Mar 10
http://online.wsj.com/article/SB114195740527094405.html
HSL5071
Burton TM.
Blood-substitute study is criticized by U.S. agency
Wall St J (East Ed) 2006 Mar 10;A3
HSL20200
Jenkins R
AMA on offensive over Xenical ads
Australian Doctor 2006 Mar 103
http://www.australiandoctor.com.au/news/latest-news/ama-on-offensive-over-xenical-ads
HSL3851
Theobald B.
Frist a frequent flier on drug companies' jets
Tennessean online 2006 Mar 9
http://tennessean.com/apps/pbcs.dll/article?AID=/20060309/NEWS02/603090417/1358
HSL3858
FTC Testifies on Dietary Supplements
Federal Trade Commision ( USA ) 2006 Mar 9
http://www.ftc.gov/opa/2006/03/dietarysupplements.htm
HSL3866
Cook T.
Saskatchewan government nixes funding for expensive cancer drug Avastin
Canadian Press 2006 Mar 9
http://aol.mediresource.com/channel_health_news_details.asp?news_id=9480&news_channel_id=12&channel_id=12
HSL3903
Roner L.
Is more money the answer to improved drug safety monitoring?
Eye For Pharma 2006 Mar 9
http://www.eyeforpharma.com/index.asp?nli=o&g-p&nld=3/10/2006&news=50079
HSL3852
Saul S.
Some Sleeping Pill Users Range Far Beyond Bed
New York Times 2006 Mar 8
http://topics.nytimes.com/top/reference/timestopics/people/s/stephanie_saul/index.html?inline=nyt-per
HSL3854
Abelson R.
Pay Method Said to Sway Drug Choices of Oncologists
New York Times 2006 Mar 8
http://www.nytimes.com/2006/03/08/health/08docs.html?_r=1&oref=slogin
HSL3862
Pfizer sues P&G over mouthwash TV ads
PM Live.com 2006 Mar 7
http://www.pmlive.com/doaa/news.cfm?showArticle=1&ArticleID=4455
HSL3905
Fox M.
Lengthy drug testing not to blame for prices:study
Reuters 2006 Mar 7
http://www.nlm.nih.gov/medlineplus/news/fullstory_30690.html
HSL3856
Lask S.
Ambien Class Action Filed in NY Federal Court: Warnings Needed About Adverse Side Effects
SCL Law Offices 2006 Mar 6
http://www.appellate-brief.com/ambien.html
HSL3857
Wonder Drug Inspires Deep, Unwavering Love Of Pharmaceutical Companies
The Onion 2006 Mar 6
http://www.theonion.com/content/node/46032
HSL3863
Swan N.
Cancer Screening - Benefits and Harms ( three part series)
Health Report ( ABC Radio National - Australian Broadcasting Commission) 2006 Mar 6
http://www.abc.net.au/rn/healthreport/stories/2006/1582008.htm#
HSL3840
Cassels A.
Sleeping pill war will keep you awake
Common Ground ( Canada) 2006 Mar 4
http://www.commonground.ca/iss/0603176/cg176_cassels.shtml
HSL3846
Harris G.
New Drugs Hit the Market, but Promised Trials Go Undone
New York Times 2006 Mar 4
New Drugs Hit the Market, but Promised Trials Go Undone
HSL3844
Former New England Journal editor calls for firing of CMAJ publisher
Canadian Press 2006 Mar 3
http://bodyandhealth.canada.com/channel_health_news_details.asp?news_id=9428&news_channel_id=131&channel_id=131&rot=11
HSL3847
Bridges A.
FDA: Drug Companies Drop Ball on Studies
Associated Press ( here on Forbes) 2006 Mar 3
http://www.forbes.com/home/feeds/ap/2006/03/03/ap2569865.html
HSL3864
Langreth R.
Asthma Drug Warning Strengthened
Forbes.com 2006 Mar 3
http://www.forbes.com/technology/sciences/2006/03/03/glaxosmithkline-advair-0303markets16.html
HSL5045
Cardarelli R, Licciardone JC, Taylor LG.
A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?
BMC Fam Pract 2006 Mar 3;7:(13):
http://www.biomedcentral.com/1471-2296/7/13
HSL5492
There is no "Away" - Pharmaceuticals, Personal Care Products, and Endocrine-Disrupting Substances: Emerging Contaminants Detected in Water
Canadian Institute for Environmental Law andPolicy ( see http://www.cielap.org/ ) 2006 Mar 3
http://cielap.org/pdf/NoAway.pdf
HSL3841
Stanford Doctors Spotlight Fatal Flaw in Multiple Sclerosis Drug Trial
Home Business Wire 2006 Mar 2
http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060302005234&newsLang=en
HSL3845
Goozner M.
Oncologists Rebel Against Amgen's Marketing Tactics
GoozNews 2006 Mar 2
http://www.gooznews.com/
HSL4546
Hilliard T, Chambers T.
The relationship between paediatricians and commerce.
Paediatr Respir Rev 2006 Mar;7:(1):54-9
http://linkinghub.elsevier.com/retrieve/pii/S1526-0542(05)00086-2
HSL4548
Netzer T.
European Union centralised procedure for marketing authorisation of oncology drugs: an in-depth review of its efficiency.
Eur J Cancer 2006 Mar;42:(4):446-55
HSL4860
Jeppsson A.
[Drug development costs are overstated by the industry].
Lakartidningen 2006 Mar 1-7;103:(9):663-4
HSL4862
Anderson JC, Narus JA, van Rossum W.
Customer value propositions in business markets.
Harv Bus Rev 2006 Mar 01;84:(3):90-9,
HSL4976
Boyce P.
Restoring wisdom to the practice of psychiatry.
Australas Psychiatry 2006 Mar 01;14:(1):3-7
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1665.2006.02241.x
HSL4983
Sikora C.
Whose pen is in your pocket?
Can Fam Physician 2006 Mar 01;52:394-5
HSL4985
Drowning or thirsting: the extremes of availability of medical information.
PLoS Med 2006 Mar 01;3:(3):e165
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030165
HSL4986
Smith R.
The trouble with medical journals.
J R Soc Med 2006 Mar 01;99:(3):115-9
http://www.jrsm.org/cgi/content/full/99/3/115
HSL4989
Leather DA, Davis SC.
Paediatricians and the pharmaceutical industry: an industry perspective of the challenges ahead.
Paediatr Respir Rev 2006 Mar 01;7:(1):60-6
http://linkinghub.elsevier.com/retrieve/pii/S1526-0542(05)00117-X
HSL5131
Engelman K.
Rx: professional integrity (prn).
J Clin Hypertens (Greenwich) 2006 Mar 01;8:(3):232
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3351&uid=16578956&db=PubMed&url=http://www.lejacq.com/articleDetail.cfm?pid=JClinHypertens_8;3:232
HSL5143
Pickering TG.
Class effects and labeling of antihypertensive drugs.
J Clin Hypertens (Greenwich) 2006 Mar 01;8:(3):215-20
http://www.lejacq.com/Search_ArticleDetail.cfm?PID=JClinHypertens_8;3:215&CFID=1084529&CFTOKEN=12638004
HSL5158
Levin PJ, McGee G.
Physician, divest thyself.
Am J Bioeth 2006 Mar-Apr 01;6:(2):1-2
http://taylorandfrancis.metapress.com/(xejiig55vu0ome45n4xojl45)/app/home/contribution.asp?referrer=parent&backto=issue,1,44;journal,2,25;linkingpublicationresults,1:111605,1
HSL5159
Salerno RA, Lesko LJ.
Three years of promise, proposals, and progress on optimizing the benefit/risk of medicines: a commentary on the 3rd FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop.
Pharmacogenomics J 2006 Mar-Apr 01;6:(2):78-81
http://www.nature.com/tpj/journal/v6/n2/abs/6500345a.html
HSL5219
Mack J.
Counterpoint: biotech needs more than DTC as usual.
Nat Biotechnol 2006 Mar 01;24:(3):267
http://www.nature.com/nbt/journal/v24/n3/full/nbt0306-267.html
HSL5220
Oestreicher P, Warner T.
Point: Biotech needs direct to consumer communications.
Nat Biotechnol 2006 Mar 01;24:(3):265-6
http://www.nature.com/nbt/journal/v24/n3/full/nbt0306-265b.html
HSL5375
Ruiz JG, Mintzer MJ, Leipzig RM.
The impact of E-learning in medical education.
Acad Med 2006 Mar 01;81:(3):207-12
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=1040-2446&volume=81&issue=3&spage=207
HSL5394
Toure JT, Brandt NJ, Limcangco MR, Briesacher BA.
Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
Am J Geriatr Pharmacother 2006 Mar 01;4:(1):25-35
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B7CWH-4K21XJX-4&_coverDate=03%2F31%2F2006&_alid=421182227&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=18107&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=31062f4086f658175dddcec0c0b8359b
HSL5443
Ferrara J.
Personalized medicine: challenges in assessing and capturing value in the commercial environment.
Expert Rev Mol Diagn 2006 Mar 01;6:(2):129-31
http://www.future-drugs.com/doi/abs/10.1586/14737159.6.2.129
HSL5556
Kolch M, Lippert HD, Fegert JM.
[The effects of the 12th and 14th amendments to the AMG (Medical Preparations Act) on paediatric pharmaceutical research--a survey of the new regulations].
Z Kinder Jugendpsychiatr Psychother 2006 Mar 01;34:(2):117-26
HSL5557
Wick JY, Zanni GR.
Biogenerics: potential benefits and obstacles.
Consult Pharm 2006 Mar 01;21:(3):208-12,
HSL5665
Dandona L.
Clinical trials in India: balancing economic opportunity with the public health context.
Natl Med J India 2006 Mar-Apr 01;19:(2):57-9
HSL5672
Winterstein AG, Hartzema AG, Johns TE, De Leon JM, McDonald K, Henshaw Z, Pannell R.
Medication safety infrastructure in critical-access hospitals in Florida.
Am J Health Syst Pharm 2006 Mar 1;63:(5):442-50
http://www.ajhp.org/cgi/content/full/63/5/442
HSL5673
Traynor K.
FDA resurrects, finalizes labeling rule.
Am J Health Syst Pharm 2006 Mar 1;63:(5):398,
http://www.ajhp.org/cgi/content/full/63/5/398
HSL5778
Nunn AD.
The cost of developing imaging agents for routine clinical use.
Invest Radiol 2006 Mar 01;41:(3):206-12
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00004424-200603000-00002
HSL5833
Macdonald AJ.
Financial support and conflict of interest.
Br J Psychiatry 2006 Mar 01;188:294
http://bjp.rcpsych.org/cgi/content/full/188/3/294
HSL6074
DeSilets LD.
Commercial support for professional development.
J Contin Educ Nurs 2006 Mar-Apr 01;37:(2):52-3
HSL6076
Felsenfeld AL.
How sweet it isn't.
J Calif Dent Assoc 2006 Mar 01;34:(3):193-4
HSL6086
Demonaco HJ, Ali A, Hippel E.
The major role of clinicians in the discovery of off-label drug therapies.
Pharmacotherapy 2006 Mar 01;26:(3):323-32
http://www.atypon-link.com/doi/abs/10.1592/phco.26.3.323
HSL6087
Joppi R, Bertele V, Garattini S.
Orphan drug development is progressing too slowly.
Br J Clin Pharmacol 2006 Mar 01;61:(3):355-60
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2125.2006.02579.x
HSL6088
Aronson JK.
Rare diseases and orphan drugs.
Br J Clin Pharmacol 2006 Mar 01;61:(3):243-5
HSL6143
Carvalho MC, Accioly Junior H, Raffin FN.
[Social representations of generic drugs by consumers from Natal, Rio Grande do Norte, Brazil].
Cad Saude Publica 2006 Mar 01;22:(3):653-61
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2006000300020&tlng=es&lng=en&nrm=iso
HSL6269
Grabowski HG, Wang YR.
The quantity and quality of worldwide new drug introductions, 1982-2003.
Health Aff (Millwood) 2006 Mar-Apr 01;25:(2):452-60
http://content.healthaffairs.org/cgi/content/full/25/2/452
HSL6270
Ridley DB, Kramer JM, Tilson HH, Grabowski HG, Schulman KA.
Spending on postapproval drug safety.
Health Aff (Millwood) 2006 Mar-Apr 01;25:(2):429-36
http://content.healthaffairs.org/cgi/content/full/25/2/429
HSL6271
Adams CP, Brantner VV.
Estimating the cost of new drug development: is it really 802 million dollars?
Health Aff (Millwood) 2006 Mar-Apr 01;25:(2):420-8
http://content.healthaffairs.org/cgi/content/full/25/2/420
HSL6272
Ridley DB, Grabowski HG, Moe JL.
Developing drugs for developing countries.
Health Aff (Millwood) 2006 Mar-Apr 01;25:(2):313-24
http://content.healthaffairs.org/cgi/content/full/25/2/313
HSL6273
Drugs and vaccines around the world.
Health Aff (Millwood) 2006 Mar-Apr 01;25:(2):312
http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?itool=Citation-def&PrId=3051&uid=16522572&db=PubMed&url=http://content.healthaffairs.org/cgi/pmidlookup?view=long&pmid=16522572
HSL4632
Doran E, Kerridge I, McNeill P, Henry D.
Empirical uncertainty and moral contest: a qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia.
Soc Sci Med 2006 Mar;62:(6):1510-9
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-4H21NFX-1&_coverDate=03%2F31%2F2006&_alid=400810064&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5925&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=165ba1a1d91dd24eb1902c511a325900
HSL4869
Maclure M, Nguyen A, Carney G, Dormuth C, Roelants H, Ho K, Schneeweiss S.
Measuring prescribing improvements in pragmatic trials of educational tools for general practitioners.
Basic Clin Pharmacol Toxicol 2006 Mar;98:(3):243-52
Randomized pragmatic trials of drugs, physician education and drug policies are needed to improve pharmacosurveillance and cost-effectiveness of prescribing. Since 1994, we have developed and tested methods for low-cost education and policy trials to improve prescribing in primary care in Canada. We review methodology for using drug claims and other health services data to evaluate prescribing improvement programs and policies. We apply the lessons to a proposed trial of physician education tools (PET) for quality improvement of prescribing. Design issues for the trial include defining the potential programme in causal terms using counterfactuals, narrowing the denominator to the population affected, excluding noise from the numerator, calculating the prescribing preference, adjusting for baseline differences, controlling for modifiers and confounders, accounting for uncertainty when measuring impacts, and grouping practices for feedback and recognition. Data from a randomized trial of academic detailing illustrate measurement challenges. A decade of progress on methods for evaluating prescribing improvement programs with drug claims data has enabled planning of routine randomized pragmatic trials of education and policies in primary care in Canada.
HSL4876
Hoodia: lose weight without feeling hungry?
Consum Rep 2006 Mar;71:(3):49
HSL4926
Smith CA, Coyle ME.
Recruitment and implementation strategies in randomised controlled trials of acupuncture and herbal medicine in women's health.
Complement Ther Med 2006 Mar;14:(1):81-6
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048&uid=16473758&db=PubMed&url=http://linkinghub.elsevier.com/retrieve/pii/S0965-2299(05)00080-4
HSL5067
Somberg JC.
Pharmaceutical companies and medical therapeutics education.
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3159&uid=16645422&db=PubMed&url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00045391-200603000-00001 Am J Ther 2006 Mar-Apr;13:(2):93
HSL5072
Lohiya S.
A simple stratification & storage system for samples and supplies.
J Natl Med Assoc 2006 Mar;98:(3):405-7
HSL5076
Kim PS.
Reply to 'Truth in numbers'.
Nat Med 2006 Mar;12:(3):269
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3094&uid=16520764&db=PubMed&url=http://dx.doi.org/10.1038/nm0306-269a
HSL5077
Wadman M.
One year after launch, drug safety board is dubbed a failure.
Nat Med 2006 Mar;12:(3):258
http://www.nature.com/doifinder/10.1038/nm0306-258b
HSL7414
Consumers Union of the US
Prescription for Change
: Consumers Union of the US 2006 Mar
http://www.consumersunion.org/pdf/drugreps.pdf
HSL7701
Morgan SG, McMahon M, Mitton C, Roughead E, Kirk R, Kanavos P, Menon D.
Centralized drug review processes in Australia, Canada, New Zealand, and the United kingdom.
Health Aff (Millwood) 2006 Mar-Apr;25:(2):337-47
http://content.healthaffairs.org/cgi/content/full/25/2/337
HSL10881
Lobo FS, Wagner S, Gross CR, Schommer JC.
Addressing the issue of channeling bias in observational studies with propensity scores analysis.
Res Social Adm Pharm 2006 Mar;2:(1):143-51
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17138506&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL10882
Altagracia-Martinez M, Kravzov-Jinich J, Guadarrama-Atrizco MD, Rubio-Poo C, Wertheimer AI.
Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
Res Social Adm Pharm 2006 Mar;2:(1):22-37
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17138499&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL12209
Bálint GP, Kean WF, Buchanan WW.
Sir William Osler (1849-1919): his opinion of modern therapeutics.
Scott Med J 2006 Mar;51:(1):51-3
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16562428
HSL17539
Girona-Brumós L, Ribera-Montañá R, Carlos Juárez-Giménez J, Pilar Lalueza-Broto M.
[Positive and negative aspects of pharmaceutical services in Spain: about antidepressants and antipsychotics].
Gac Sanit 2006 Mar;20:
http://www.elsevier.es/revistas/ctl_servlet?_f=7264&articuloid=13086038&revistaid=138
HSL10859
Pollard R.
Doctors fear run on quick-fix diet pill
Sydney Morning Herald 2006 Feb 28
http://www.smh.com.au/news/national/doctors-fear-run-on-quickfix-diet-pill/2006/02/27/1141020023615.html
Page 116 of 206 pages ‹ First < 114 115 116 117 118 > Last ›
